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Abstract
Background: Cigarette smoking is associated with an increased risk of type 2 diabetes mellitus (T2DM). Smokers
exhibit low circulating levels of total adiponectin (ADPN) and high-molecular-weight (HMW) ADPN multimers.
Blood concentrations of HMW ADPN multimers closely correlate with insulin sensitivity for handling glucose. How
tobacco smoke exposure lowers blood levels of ADPN, however, has not been investigated. In the current study,
we examined the effects of tobacco smoke exposure in vitro and in vivo on the intracellular and extracellular
distribution of ADPN and its HMW multimers, as well as potential mechanisms.
Findings: We found that exposure of cultured adipocytes to tobacco smoke extract (TSE) suppressed total ADPN
secretion, and TSE administration to mice lowered their plasma ADPN concentrations. Surprisingly, TSE caused
intracellular accumulation of HMW ADPN in cultured adipocytes and in the adipose tissue of wild-type mice,
while preferentially decreasing HMW ADPN in culture medium and in plasma. Importantly, we found that TSE
up-regulated the ADPN retention chaperone ERp44, which colocalized with ADPN in the endoplasmic reticulum.
In addition, TSE down-regulated DsbA-L, a factor for ADPN secretion.
Conclusions: Tobacco smoke exposure traps HMW ADPN intracellularly, thereby blocking its secretion. Our results
provide a novel mechanism for hypoadiponectinemia, and may help to explain the increased risk of T2DM in
smokers.
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Findings
Introduction
Over 1.3 billion people smoke worldwide, and even
more are exposed to second-hand smoke. Smokers
often exhibit impairments in insulin-mediated glucose
handling and an increased incidence of type 2 diabetes
mellitus (T2DM) [1]. Smoking cessation improves these
conditions [2]. Nevertheless, mechanisms by which
smoking impairs insulin-stimulated glucose metabolism
and increases T2DM are still unclear.
Adiponectin (ADPN), an insulin-sensitizing adipokine
secreted from adipose tissue, circulates in three different
multimeric forms – namely, trimers (low molecular-
weight, LMW), heximers (medium molecular-weight,
MMW), and larger multimers (high molecular-weight,
HMW) [3]. HMW ADPN is considered the most active
form of ADPN [4,5], and peripheral insulin sensitivity
for handling glucose closely correlates with blood levels
of HMW ADPN [3-6]. Smokers exhibit low blood levels
of total [6,7] and HMW [8] ADPN, while smoking cessa-
tion has been shown to restore blood levels of total
ADPN [9,10]. Similarly, in mice, tobacco smoke expos-
ure decreases blood ADPN [11]. How tobacco smoke
exposure lowers blood levels of ADPN, however, has not
been investigated [10]. In the current study, we sought
to determine the potential effects of tobacco smoke
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exposure on ADPN multimerization and secretion, as




We purchased polyclonal antibodies against mouse adipo-
nectin and ERp44 (endoplasmic reticulum [ER] resident
protein of 44 kDa) from Cell Signaling. Monoclonal
antibodies against Ero1 L-α (ER oxidoreductase 1-Lα) and
GAPDH, as well as secondary antibodies (anti-rabbit and
anti-mouse IgG horseradish peroxidase conjugates), were
from Santa Cruz. The antibody against DsbA-L (disulfide-
bond A oxidoreductase-like protein) was from Abcam.
Tobacco smoke extract (TSE, 100%) with water-soluble
components was prepared by using a Kontes gas-washing
bottle to bubble mainstream smoke from research ciga-
rettes through serum-free, phenol red-free RPMI media
containing 0.2% BSA (RPMI/BSA), followed by filtration
(0.22 μm) and standardization according to their absorb-
ance at 320 nm, as we previously published [12,13].
Cell culture, preparation of primary mouse adipocytes,
and TSE exposure
Murine 3T3-L1 preadipocytes (ATCC) were cultured
and differentiated into adipocytes as described [14].
Briefly, two days after reaching 100% confluence, the
cells were stimulated for an additional two days with
FBS/DMEM containing 100 nM insulin, 0.5 M IBMX,
0.25 μM dexamethasone, and 1 μM rosiglitazone. Cells
were then maintained in FBS/DMEM medium with 100
nM insulin for another 2 days to differentiate into ma-
ture adipocytes with fat droplets. Cells were serum-
starved for 3 h in DMEM containing 0.2% BSA, followed
by exposure to 0–1.5% TSE for 0-20 h. Primary mouse
adipocytes were prepared as described [15]. Briefly,
epididymal adipose tissue from wild-type C57BL/6 mice
(Jackson Laboratory) was placed in pre-warmed DMEM
with 10% FBS and penicillin/streptomycin, and then
minced into 5–10 mg pieces. Minced tissue fragments were
filtered through a nylon mesh (350-μm pore size) and
washed with DMEM. Then 200-300 mg of minced, filtered
tissue was placed into 1 ml DMEM with 0.2% BSA and
penicillin/streptomycin for 18 h before being treated
without or with 1.5% TSE for an additional 20 h. At the
end, the supernatants were collected and the explants were
lysed for ADPN immunoblots.
TSE exposure of wild type mice
To mimic the effects of tobacco smoke exposure on a
non-respiratory organ with well-controlled dosing, we
followed the recently established methodology of intra-
peritoneal administration of TSE [16-18]. Wild-type
mice were injected intraperitoneally in the lower left
quadrant of the abdomen with 400 μl of pre-warmed,
filtered TSE diluted to 20% strength in RPMI-1640 (this
amount of TSE is equivalent to smoking 2 packs of
cigarettes for a 60-kg person) or RPMI-1640 alone (control)
on days 1, 3, 5, 8, and 10 [16]. Twenty-four hours after the
final injection, the mice were euthanized by an overdose of
pentobarbital. We collected whole blood by cardiac punc-
ture and then epididymal adipose tissue from the lower
right abdominal quadrant, away from the application sites.
All animal protocols were approved by the Institutional
Animal Care and Use Committee of the Philadelphia
Veterans Administration Medical Center.
Immunoblots
Immunoblots were performed as described in our previous
publications [12,13]. For detection of adiponectin oligomers
and multimers, cells were lysed in non-reducing lysis buf-
fer and loaded onto a gel without boiling.
Determination of adiponectin concentration
Total adiponectin concentrations in conditioned media
from control and TSE-treated 3T3-L1 adipocytes and in
plasma from control and TSE-treated mice were measured
by ELISA for mouse ADPN according to the manufac-
turer’s instruction (BioVendor).
Data analysis
All column and line graphs depict mean ± SEM of data
that passed tests for normality. Comparisons amongst
three or more groups were performed using one-way
analysis of variance (ANOVA), followed by pairwise
comparisons using Student-Newman-Keuls (SNK) test,
with p < 0.05 considered significant. Comparisons between
two groups used Student’s unpaired, two-tailed t-test.
Results and discussion
Tobacco smoke exposure decreases secretion of ADPN
while inducing its intracellular accumulation
We found that TSE exposure caused dose- and time-
dependent suppression of total ADPN secretion from
3T3-L1 adipocytes, while increasing total intracellular
ADPN detected by immunoblots (Figure 1A-1D). Viability
of the adipocytes was unaffected by these low concentra-
tions of TSE (not shown). Inhibition of total ADPN
secretion into the conditioned medium from TSE exposed
3T3-L1 adipocytes was confirmed by ADPN ELISA
(Figure 1E). In addition, exposure of mouse primary adipo-
cytes to 1.5% TSE ex vivo for 20 h significantly suppressed
ADPN secretion, while increasing intracellular ADPN con-
tent (Figure 1F). Importantly, exposure of mice to TSE also
induced a large decrease in plasma concentrations of total
ADPN in vivo (Figure 1G), consistent with prior publica-
tions in smoke-exposed mice [11] and in human smokers
[6,7]. Thus, smoke-induced retention of ADPN within
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Figure 1 Tobacco smoke exposure decreases secretion of ADPN while inducing its intracellular accumulation. Panels A,B: Representative
immunoblots (A) and summary statistics (B) for dose-dependent effects of TSE on ADPN accumulation in conditioned medium and in cellular
homogenates of 3T3-L1 adipocytes during a 20-h incubation. Panels C,D: Representative immunoblots (C) and summary statistics (D) of the time
course of the effects of TSE on ADPN accumulation in conditioned medium and in cellular homogenates of 3T3-L1 adipocytes exposed to 1.5%
TSE for 0-20 h. Panel E: ADPN concentrations measured by ELISA in the culture supernatants of 3T3-L1 adipocytes exposed for 20 h to 0 (control)
or 1.5% TSE . Panel F: Immunoblots of ADPN in conditioned medium and in cellular homogenates of primary mouse adipocytes treated without
or with 1.5% TSE for 20 h. Panel G: Immunoblots of total plasma ADPN in mice after RMPI (Control) or TSE injections. Panels B, D, E, G, n = 3-5.
In panels B and D, P < 0.01 by ANOVA of all cellular values, and P < 0.01 by ANOVA of all medium values. *P < 0.05, **P < 0.01, ***P < 0.001 vs.
control values (0% TSE or t = 0) by the SNK test. In panels E and G, Student’s t-test was used.
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adipocytes contributes to the decreased secretion of ADPN
from adipose tissue and low plasma levels of ADPN in
smokers [6,7,9,10].
Tobacco smoke exposure traps HMW ADPN intracellularly
Among the three different multimeric forms of ADPNs,
HMW ADPN has been shown to be the most biologic-
ally active [4,5] in promoting insulin-induced glucose
handling [3-6]. In the current study, we assessed the
three major multimeric forms of ADPNs by immuno-
blots under non-reducing conditions [19]. We found
that the decrease in total ADPN secretion from cultured
373-L1 adipocytes after TSE exposure (Figure 1A-E) was
mainly attributable to decreased secretion of HMW
ADPN (Figure 2A,B), accompanied by increased intra-
cellular accumulation of HMW ADPN (Figure 2A,B).
Likewise, we found that mice injected with TSE exhib-
ited a loss of mainly HMW ADPN from plasma (Figure
2C) and HMW ADPN accumulated in their adipose
tissue (Figure 2D).
Tobacco smoke exposure dysregulates the expression of
ADPN chaperones
Assembly and secretion of adiponectin oligomers from
adipocytes is tightly regulated by thiol redox status in
the ER through ERp44 and Ero1-Lα [20,21]. ERp44 is an
ER resident chaperone that inhibits the secretion of
ADPN through thiol-mediated retention, while Ero1-Lα
Figure 2 Tobacco smoke exposure traps HMW ADPN intracellularly. Panels A,B: Representative immunoblots of ADPN isoforms (A) and summary statistics
for the ratio of HMW/LMW ADPN (B) in conditioned medium and cellular homogenates from 3T3-L1 adipocytes treated with 0% (control) or 1.5% TSE
for 20 h. Isoforms of ADPN were separated by electrophoresis through 2–15% SDS-PAGE gradient gels under nonreducing and non-heat-denaturing
conditions. Panel B displays means ± SEM, n = 4; P-values were computed using Student’s t-test. Panels C, D: Representative immunoblots showing the
distribution of ADPN isoforms in plasma (C) and in epididymal adipose tissue (D) from wild-type mice after RPMI (control) or TSE injections.
Figure 3 Tobacco smoke exposure dysregulates the expression of
ADPN chaperones. Panel A shows representative immunoblots for time-
dependent effects of TSE on the expression of ERp44, Ero1-Lα, and
DsbA-L in 3T3-L1 adipocytes exposed to 1.5% TSE for 0-20 h. Panel B
shows confocal fluorescent micrographs of representative 3T3-L1 cells
that were stained simultaneously with anti-ERp44 (red) and anti-ADPN
(green) antibodies, as well as DAPI (blue; nuclear stain). The yellow color
in the merged images (Merge) demonstrates co-localization of ERp44
and ADPN in the ER around the nucleus.
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releases HMW adiponectin from ERp44 [20,21]. In
addition, DsbA-L has been shown to promote adiponec-
tin multimerization and secretion [22,23]. In the current
study, we found that TSE exposure of cultured adipo-
cytes induced time- (Figure 3A) and dose- (not shown)
dependent up-regulation of ERp44 and down-regulation
of DsbA-L. TSE exposure, however, did not affect the
amount of Ero1-Lα in adipocytes (Figure 3A), suggesting
that the high intracellular levels of ERp44 would be un-
opposed. Additionally, our confocal microscopic analyses
revealed that TSE exposure of adipocytes increased
intracellular staining for ERp44 (red) and ADPN (green,
Figure 3B). Importantly, this intracellular ADPN coloca-
lized with ERp44 (yellow color in the merged images,
Figure 3B), indicating ADPN accumulation in the ER,
presumably physically associated with ERp44.
We conclude that tobacco smoke exposure suppresses
ADPN secretion from adipocytes by specifically trapping
HMW ADPN intracellularly, thereby contributing to de-
creased blood levels of ADPN in smokers. These results
provide a novel mechanism for hypoadiponectinemia,
which may help to explain impaired insulin-mediated
glucose handling and the increased risk of T2DM in
smokers.
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